In this study, we identified that the decrease in K612 lactylation is a critical pathological change leading to APP amyloidogenic processing in AD brains using mass spectroscopy and a lactyl-mimicking mutant (APPK612T). This evidence concerns the gene APP and Alzheimer disease.